ResearcherEulji UniversityNo recent work listed
Jung‐Soo Pyo
Matched on ORCID iD 0000-0003-0320-8088; OpenAlex author ID A5003431248. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 3
- Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol28060371↗
- Prognostic Implication of pN Stage Subdivision Using Metastatic Lymph Node Ratio in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/1066896919886057↗
- Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio. First author DOI 10.1155/2018/9745601↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Byoung Kwan Son · 3 shared papers, 2018–2021 · strength 0.47
- Paper Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/curroncol28060371↗
- Paper Prognostic Implication of pN Stage Subdivision Using Metastatic Lymph Node Ratio in Resected Pancreatic Ductal Adenocar… DOI 10.1177/1066896919886057↗
- Paper Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio an… DOI 10.1155/2018/9745601↗
- Kwang Hyun Chung · 2 shared papers, 2020–2021 · strength 0.33
- Paper Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/curroncol28060371↗
- Paper Prognostic Implication of pN Stage Subdivision Using Metastatic Lymph Node Ratio in Resected Pancreatic Ductal Adenocar… DOI 10.1177/1066896919886057↗
- Dongwook Oh · 1 shared paper, 2018 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.